| Literature DB >> 24998929 |
Raphael Bernier1, Christelle Golzio2, Bo Xiong3, Holly A Stessman3, Bradley P Coe3, Osnat Penn3, Kali Witherspoon3, Jennifer Gerdts1, Carl Baker3, Anneke T Vulto-van Silfhout4, Janneke H Schuurs-Hoeijmakers4, Marco Fichera5, Paolo Bosco6, Serafino Buono6, Antonino Alberti6, Pinella Failla6, Hilde Peeters7, Jean Steyaert8, Lisenka E L M Vissers4, Ludmila Francescatto2, Heather C Mefford9, Jill A Rosenfeld10, Trygve Bakken11, Brian J O'Roak12, Matthew Pawlus13, Randall Moon14, Jay Shendure3, David G Amaral15, Ed Lein11, Julia Rankin16, Corrado Romano6, Bert B A de Vries4, Nicholas Katsanis2, Evan E Eichler17.
Abstract
Autism spectrum disorder (ASD) is a heterogeneous disease in which efforts to define subtypes behaviorally have met with limited success. Hypothesizing that genetically based subtype identification may prove more productive, we resequenced the ASD-associated gene CHD8 in 3,730 children with developmental delay or ASD. We identified a total of 15 independent mutations; no truncating events were identified in 8,792 controls, including 2,289 unaffected siblings. In addition to a high likelihood of an ASD diagnosis among patients bearing CHD8 mutations, characteristics enriched in this group included macrocephaly, distinct faces, and gastrointestinal complaints. chd8 disruption in zebrafish recapitulates features of the human phenotype, including increased head size as a result of expansion of the forebrain/midbrain and impairment of gastrointestinal motility due to a reduction in postmitotic enteric neurons. Our findings indicate that CHD8 disruptions define a distinct ASD subtype and reveal unexpected comorbidities between brain development and enteric innervation.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24998929 PMCID: PMC4136921 DOI: 10.1016/j.cell.2014.06.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582